Radioiodinated phenylalanine derivatives to image pancreatic cancer: A comparative study with [18F]fluoro-2-deoxy-d-glucose in human pancreatic carcinoma xenografts and in inflammation models

Nuclear Medicine and Biology

Volumn 32, Issue 2, 2005, Pages 137-145

  Hellwig, Dirk ^a   Menges, Markus ^a   Schneider, Günther ^a   Moellers, Marc Oliver ^a   Romeike, Bernd F ^a   Menger, Michael D ^a   Kirsch, Carl Martin ^a   Samnick, Samuel ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Amino acid tracers; In vivo model; Noninvasive imaging; Pancreatic cancer; SCID mouse

Indexed keywords

4 AMINO 3 IODOPHENYLALANINE I 123; 4 IODOPHENYLALANINE I 123; CONCANAVALIN A; FLUORODEOXYGLUCOSE F 18; PHENYLALANINE DERIVATIVE; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER DIAGNOSIS; CANCER INVASION; CANCER TRANSPLANTATION; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; DRUG DISTRIBUTION; DRUG POTENCY; DRUG SCREENING; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; INOCULATION; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOTOPIC TRANSPLANTATION; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RADIOIODINATION; SCID MOUSE; TUMOR XENOGRAFT;

EID: 13844313473     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.09.005     Document Type: Article

References (33)

1. A.W. Warshaw, and C. Fernandez-del Castillo Pancreatic carcinoma N. Engl. J. Med. 326 1992 455 465
2. J. Faivre, D. Forman, J. Esteve, M. Obradovic, and M. Sant Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe Eur. J. Cancer 34 1998 2184 2190
3. B. Gudjonsson Survival statistics gone awry: pancreatic cancer, a case in point J. Clin. Gastroenterol. 35 2002 180 184
4. K. Lillemore Current management of pancreatic cancer Ann. Surg. 221 1995 133 148
5. M. Schafer, B. Mullhaupt, and P.A. Clavien Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis Ann. Surg. 236 2002 137 148
6. B.M. Mueller, and R.A. Reisfeld Potential of the SCID mouse as a host for human tumors Cancer Metastasis Rev. 10 1991 193 200
7. V. Leblond, B. Autran, and J.Y. Cesbron The SCID mouse mutant: definition and potential use as a model for immune and hematological disorders Hematol. Cell Ther. 39 1997 213 221
8. J.M. Carballido, R. Namikawa, N. Carballido-Perrig, S. Antonenko, M.G. Roncarolo, and J.E. de Vries Generation of primary antigen-specific human T- and B-cell responses in immunocompetent SCID-hu mice Nat. Med. 6 2000 103 106
9. L. Trümper, M. Menges, H. Daus, D. Kohler, J.O. Reinhard, and M. Sackmann Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial J. Clin. Oncol. 21 2002 4331 4337
10. E.U. Nitzsche, S. Hoegerle, M. Mix, I. Brink, A. Otte, and E. Moser Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? Eur. J. Nucl. Med. 29 2002 237 242
11. 18F-fluorodeoxyglucose- positron-emission tomography with preoperative evaluation of patients with pancreatic masses Pancreas 20 2000 109 116
12. P. Grino, J. Martinez, E. Grino, F. Carnicer, S. Alonso, and H. Perez-Berenguer Acute pancreatitis secondary to pancreatic neuroendocrine tumours JOP 4 2003 104 110
13. P.L. Jager, W. Vaalburg, J. Pruim, E.G. de Vries, K.J. Langen, and D.A. Piers Radiolabeled amino acids: basic aspects and clinical applications in oncology J. Nucl. Med. 42 2001 432 445
14. P. Laverman, O.C. Boerman, F.H. Corstens, and W.J. Oyen Fluorinated amino acids for tumour imaging with positron emission tomography Eur. J. Nucl. Med. Mol. Imaging 29 2002 681 690
15. F.C. Rau, W.A. Weber, H.J. Wester, M. Herz, I. Becker, and A. Kruger O-(2-[(18)F]Fluoroethyl)-l-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes Eur. J. Nucl. Med. Mol. Imaging 29 2002 1039 1046
16. T. Miyagawa, T. Oku, H. Uehara, R. Desai, B. Beattie, and J. Tjuvajev "Facilitated" amino acid transport is upregulated in brain tumors J. Cereb. Blood Flow Metab. 18 1998 500 509
17. K.J. Langen, D. Pauleit, and H.H. Coenen 3-[(123)I]Iodo-alpha-methyl-l- tyrosine: uptake mechanisms and clinical applications Nucl. Med. Biol. 29 2002 625 631
18. M. Blau, and M.A. Bender Se 75-selenomethionine for visualization of the pancreas by isotope scanning Radiology 78 1962 974
19. L.C. Washburn, T.T. Sun, B.L. Byrd, R.L. Hayes, and T.A. Butler dl-[Carboxyl-11C]tryptophan, a potential agent for pancreatic imaging; production and preclinical investigations J. Nucl. Med. 20 1979 857 864
20. K.F. Hubner, G.A. Andrews, E. Buonocore, R.L. Hayes, L.C. Washburn, and I.R. Collmann Carbon-11-labeled amino acids for the rectilinear and positron tomographic imaging of the human pancreas J. Nucl. Med. 20 1979 507 513
21. S. Samnick, A. Schaefer, S. Siebert, S. Richter, B. Vollmar, and C.M. Kirsch Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells Nucl. Med. Biol. 28 2001 13 23
22. S. Samnick, S. Richter, B.F. Romeike, A. Heimann, W. Feiden, and O. Kempski Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats Eur. J. Nucl. Med. 27 2000 1543 1551
23. T. Adachi, Y. Hinoda, I. Nishimori, M. Adachi, and K. Imai Increased sensitivity of gastric cancer cells to natural killer and lymphokine-activated killer cells by antisense suppression of N-acetylgalactosaminyltransferase J. Immunol. 159 1997 2645 2651
24. G. Schneider, P. Fries, D. Wagner-Jochem, D. Thome, H. Laurer, and B. Kramann Pathophysiological changes after traumatic brain injury: comparison of two experimental animal models by means of MRI MAGMA 14 2002 233 241
25. R. Namikawa, and E. Shtivelman SCID-hu mice for the study of human cancer metastasis Cancer Chemother. Pharmacol. 43 1999 S37 S41
26. A. Garofalo, R.G. Chirivi, E. Scanziani, J.G. Mayo, A. Vecchi, and R. Giavazzi Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice Invasion Metastasis 13 1993 82 91
27. E. Gallo-Hendrikx, J. Copps, D. Percy, B.A. Croy, and A.G. Wildeman Enhancement of pancreatic tumor metastasis in transgenic immunodeficient mice Oncogene 9 1994 2983 2990
28. R.M. Mohammad, A. Al-Katib, G.R. Pettit, V.K. Vaitkevicius, U. Joshi, and V. Adsay An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies Clin. Cancer Res. 4 1998 887 894
29. P. Mitchell, F.T. Lee, C. Hall, A. Rigopoulos, F.E. Smyth, and A.M. Hekman Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies J. Nucl. Med. 44 2003 1105 1112
30. E. Shtivelman, and R. Namikawa Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue Proc. Natl. Acad. Sci. U S A 92 1995 4661 4665
31. S.N. Reske, and J. Kotzerke FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000 Eur. J. Nucl. Med. 28 2001 1707 1723
32. 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer Int. J. Oncol. 19 2001 53 58
33. E.P. DiMagno, H.A. Reber, and M.A. Tempero AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma Gastroenterology 117 1999 1464 1484